Impact of a 7-day retreat for people with Parkinson's disease: a phenomenological study [0.03%]
帕金森病患者参加7天修养项目的影响：一项现象学研究
Lori M Bordenave,Corrine Fritcher Nelson,Becky G Farley et al.
Lori M Bordenave et al.
Aim: Early and ongoing access to rehabilitation and exercise may preserve functional mobility and quality of life for persons with Parkinson disease (PwP). The aim of the current study was to describe the experience of PwP who participated ...
Glatiramer acetate or IFN-β bridging therapy in women with relapsing multiple sclerosis planning a pregnancy [0.03%]
关于计划怀孕的复发性多发性硬化症妇女使用醋酸格拉替雷或干扰素β过渡治疗的研究
Kerstin Hellwig,Sandra Thiel,Sabrina Haben et al.
Kerstin Hellwig et al.
Aim: To assess bridging glatiramer acetate (GA) or IFN-β for relapse prevention in women with relapsing multiple sclerosis planning pregnancy. Materials & methods: Participants discontinued disease-modifying therapies (DMTs) and received G...
A plain language summary of what clinical studies can tell us about the safety of evobrutinib - a potential treatment for multiple sclerosis [0.03%]
关于evobrutinib（一种潜在的多发性硬化症治疗方法）的安全性的临床研究通俗总结
Xavier Montalban,Daniel Wallace,Mark C Genovese et al.
Xavier Montalban et al.
What is this summary about?: This summary explains the findings from a recent investigation that combined the results of over 1000 people from three clinical studies to understand the safety of evobrutinib. Evobrutinib is...
Wearable activity monitors to support physical activity interventions in neurodegenerative disease: a feasibility study [0.03%]
在神经退行性疾病中使用可穿戴活动监测设备支持身体活动干预的可行性研究
Hai-Jung Steffi Shih,Lori Quinn,Philippa Morgan-Jones et al.
Hai-Jung Steffi Shih et al.
Aim: To evaluate the feasibility of using activity monitors in a physical activity (PA) intervention in people with Parkinson's (PD) and Huntington's disease (HD). Materials & methods: People with early-stage PD (n = 13) and HD (n = 14) enr...
Exploring the impact of caring for an individual with neurogenic orthostatic hypotension: a qualitative study [0.03%]
照护患有神经源性直立性低血压患者的护理人员的照护负担:一项质性研究
Katy Gallop,Ngan Pham,Grant Maclaine et al.
Katy Gallop et al.
Aim: This study aimed to explore the impact of caring for an individual with neurogenic orthostatic hypotension (nOH). Methods: Informal caregivers of individuals with nOH and either Parkinson's disease, multiple system atrophy, pure autono...
Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease [0.03%]
靶向代谢型谷氨酸受体治疗帕金森病
Philippe Huot
Philippe Huot
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry [0.03%]
MSBase注册表中克拉利din片与其他口服药物治疗多发性硬化症有效性的plain语言总结
Tim Spelman,Serkan Ozakbas,Raed Alroughani et al.
Tim Spelman et al.
What is this summary about?: Patient registries contain anonymous data from people who share the same medical condition. The MSBase registry contains information from over 80,000 people living with multiple sclerosis (MS)...
Computerized cognitive testing in patients with Parkinson's disease: an Indian perspective [0.03%]
帕金森病患者的计算机认知测试（印度视角）
Moulika Mandal,Kashish Srivastava
Moulika Mandal
Aim: This study investigates perspectives on computer-based assessments among elderly individuals with Parkinson's disease (PD) in India for more efficient usability of digital assessments for this population. Materials & methods: Content a...
5-HT1A agonists for levodopa-induced dyskinesia in Parkinson's disease [0.03%]
五羟色胺1A受体激动剂治疗帕金森病左旋多巴诱发的异动症
Jawad Al-Kassmy,Christine Sun,Philippe Huot
Jawad Al-Kassmy
Levodopa is the most effective agent for treating the symptoms of Parkinson's disease (PD). However, levodopa-induced dyskinesia remains a significant complication that manifests after few years of treatment, for which therapeutic options r...
Interview with Nobutaka Hattori: a life researching Parkinson's disease pathogenesis [0.03%]
小堀信孝教授专访：探究帕金森病发病机制的一生
Nobutaka Hattori
Nobutaka Hattori